FFAMX
Price
$22.56
Change
-$0.07 (-0.31%)
Updated
Oct 7 closing price
Net Assets
9.97B
RLBAX
Price
$38.56
Change
-$0.09 (-0.23%)
Updated
Oct 7 closing price
Net Assets
266.1B
Interact to see
Advertisement

FFAMX vs RLBAX

Header iconFFAMX vs RLBAX Comparison
Open Charts FFAMX vs RLBAXBanner chart's image
Fidelity Advisor Asset Manager 50% A
Price$22.56
Change-$0.07 (-0.31%)
VolumeN/A
Net Assets9.97B
American Funds American Balanced R1
Price$38.56
Change-$0.09 (-0.23%)
VolumeN/A
Net Assets266.1B
FFAMX vs RLBAX Comparison Chart in %
View a ticker or compare two or three
VS
FFAMX vs. RLBAX commentary
Oct 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FFAMX is a StrongBuy and RLBAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 266B vs. FFAMX (9.97B). FFAMX pays higher dividends than RLBAX: FFAMX (1.95) vs RLBAX (1.10). FFAMX was incepted earlier than RLBAX: FFAMX (19 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than FFAMX (0.83). RLBAX is a more actively managed with annual turnover of: 44.00 vs. FFAMX (12.00). FFAMX has a lower initial minimum investment than RLBAX: FFAMX (0) vs RLBAX (250). FFAMX annual gain was more profitable for investors over the last year : 9.96 vs. RLBAX (9.12). RLBAX return over 5 years is better than : 38.04 vs. FFAMX (26.30).
FFAMXRLBAXFFAMX / RLBAX
Total Expense Ratio0.831.3163%
Annual Report Gross Expense Ratio0.831.3163%
Fund Existence19 years23 years-
Gain YTD12.79513.77093%
Front Load6%N/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets9.97B266B4%
Annual Yield % from dividends1.951.10177%
Returns for 1 year9.969.12109%
Returns for 3 years35.3447.9874%
Returns for 5 years26.3038.0469%
Returns for 10 years53.0568.7277%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WLY38.330.03
+0.09%
John Wiley & Sons
ROIV16.12-0.14
-0.86%
Roivant Sciences Ltd
PRLD1.44-0.02
-1.37%
Prelude Therapeutics
IVP0.98-0.03
-3.18%
Inspire Veterinary Partners Inc
GRRR19.99-0.68
-3.29%
Gorilla Technology Group